Axway Named a Leader in the 2024 Gartner® Magic Quadrant™ for API Management
22.10.2024 22:59:00 CEST | Business Wire | Press Release
Axway (Euronext: AXW.PA), an API Management leader, today announced that it is positioned by Gartner as a Leader in the 2024 Magic Quadrant™ for API Management for its offering, Amplify API Management.¹ The evaluation was based on specific criteria that analyzed the company’s overall completeness of vision and ability to execute. In companion research issued by Gartner along with the report, Critical Capabilities for API Management, Axway received the highest score (3.7 out of 5.0) for the Distributed API Management Use Case for the second consecutive year.²
“This is the ninth time we have been positioned as Leader in this report and I believe it reflects Axway’s dedication in this space,” said Roland Royer, CEO at Axway. “Organizations that are determined to progress and succeed in the digital world need to maximize API discovery, governance, and security everywhere. But not only that – you also need a strong platform that consolidates what you already have, to get your digital products where they can be seen and used best.”
On July 1, 2024, Axway was also positioned as a Leader in The Forrester Wave™: API Management Software, Q3 2024.³
“Axway's Amplify API Management platform has enabled us to transform our credit card onboarding process with zero implementation effort required by our business partners,” said Johann Blais, Head of Architecture and Technology at Advanzia Bank. “Advanzia has set a new industry standard by reducing application times from days to minutes, offering a fully digital and intuitive user experience and boosting customer satisfaction. The integration of real-time credit scoring, automated ID checks and secure e-signatures has increased conversion rates by 10% and allows us to issue cards 50% faster, reinforcing our position as a leader in digital banking. The Axway Amplify platform helps us deliver new user experiences across our business ecosystem with no down time and no IT hurdles."
As a true universal platform for API management, Axway Amplify Platform allows organizations to securely govern and automatically discover APIs across teams and multiple third-party APIM solutions, on-premises or in any cloud. It provides a solid – yet agile - platform for meeting tightening API security requirements and responding quickly to new opportunities using existing IT infrastructures.
“In the past, our approach to IT was heavily focused on individual projects, which led over the years to significant amounts of redundancy and complexity in our digital services,” said Marc Patterson, Lead Enterprise Architect, Highmark. “By switching to an API-driven approach, we are shifting from a project focus to a product mindset. Publishing all our digital services on a central catalog will offer our developers an instant overview of what APIs are already available — reducing duplication of effort and cutting time-to-market for new products.”
Magic Quadrant reports are a culmination of rigorous, fact-based research in specific markets, providing a wide-angle view of the relative positions of providers in markets where growth is high and provider differentiation is distinct. Providers are positioned into four quadrants: Leaders, Challengers, Visionaries and Niche Players. The research enables you to get the most from market analysis in alignment with your unique business and technology needs.
Click here to view a complimentary copy of the complete report.
¹Gartner® Magic Quadrant™ for API Management, Shameen Pillai, John Santoro, Nicholas Carter, Andrew Humphreys, Mark O'Neill, 16 October 2024
The report was published as Magic Quadrant for Application Services Governance for the year 2013 and 2015, as Magic Quadrant for Full Life Cycle API Management for 2016; 2019-2022, Axway was recognized as Axway (Vordel) in 2013.
²Gartner, Critical Capabilities for API Management, John Santoro, Andrew Humphreys, Mark O'Neill, Nicholas Carter, Shameen Pillai, 21 October 2024
³The Forrester Wave™: API Management Software, Q3 2024, Forrester Research, Inc., July 1, 2024
Gartner disclaimer
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and MAGIC QUADRANT is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
About Axway
Axway is an independent technology provider that sustainably grows enduring value for our customers based on a history of trust, security, and stability that goes back nearly 25 years. Our extensive portfolio, which encompasses Managed File Transfer, B2B Integration, Financial Accounting Hub, and comprehensive API management through Amplify, empowers organizations to seamlessly integrate their internal and external ecosystems and succeed in a shifting digital business landscape. Learn more at axway.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20241022186154/en/
Contacts
Todd Holbrook
Tel. (480) 371-0113
tholbrook@axway.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press Release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press Release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press Release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press Release
IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 patients, underscoring consistent effectiveness and safety in clinical practice. Additionally, BEQALZI™ (sonrotoclax), which was recently approved by the U.S. Food and Drug Administration, and its development in combination with BRUKINSA (ZS) highlight the potential for next-generation, time-limited treatment approaches in CLL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “CLL is a disease patients live with
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom